You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Biocon Ltd"

Biocon Ltd U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocons Proposed Biosimilar Trast

  • 11/01/2017
  • |
  • bse

Biocon Ltd Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended D

  • 07/01/2017
  • |
  • bse

Biocon Ltd Q3 results on Jan 24 2017

  • 27/12/2016
  • |
  • bse

Biocon Ltd Journal of the American Medical Association (JAMA) Publishes Mylan and Biocons Proposed Biosimilar T

  • 27/12/2016
  • |
  • bse

Biocon Ltd Intimation regarding Analysts/ Institutional Investors Meet

  • 20/12/2016
  • |
  • bse

Biocon Ltd Change in Key Managerial Personnel

  • 16/12/2016
  • |
  • bse

Biocon Ltd Intimation of Schedule of Analyst / Institutional Investor Meetings

  • 13/12/2016
  • |
  • bse

Biocon Ltd Updates

  • 13/12/2016
  • |
  • bse

Biocon Ltd Biocon Features in Asia IP Elite 2016 List

  • 09/12/2016
  • |
  • bse

Biocon Ltd Intimation regarding Analysts / Institutional Investor Meet

  • 06/12/2016
  • |
  • bse

Biocon Ltd Biocons Novel Diabetes Education Initiative for Medical Practitioners ABIDE Awarded by RSSDI

  • 29/11/2016
  • |
  • bse

Biocon Ltd Intimation regarding Analysts/ Institutional Investors Meet

  • 22/11/2016
  • |
  • bse

Biocon Ltd Intimation regarding Analysts / Institutional Investors Meet

  • 17/11/2016
  • |
  • bse

Biocon Ltd Intimation regarding Analysts/ Institutional Investors Meet

  • 15/11/2016
  • |
  • bse

Biocon Ltd Biocon Collaborates with Healthcare Professionals for a Public Awareness Campaign on Diabetes Preven

  • 11/11/2016
  • |
  • bse

Biocon Ltd Intimation regarding Analyst / Institutional Investors Meet

  • 11/11/2016
  • |
  • bse

Biocon Ltd Intimation regarding Analysts / Institutional Investors Meet

  • 09/11/2016
  • |
  • bse

Biocon Ltd Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab

  • 08/11/2016
  • |
  • bse

Biocon Ltd Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European

  • 03/11/2016
  • |
  • bse

Biocon Ltd Biocon Ranked Among Global Top Ten Biotech Employers - The only Asian Company to Feature in 2016 Ran

  • 28/10/2016
  • |
  • bse